JBS sales and earnings surge

Brazilian protein group JBS reported a jump in both sales and earnings for the first quarter of the year, progress the group attributed to its strategic initiatives and drive to become a "global" business.

The company said sales increased 28% to BRL33.8bn (US$11.12bn) in the three months to the end of March. EBITDA surged 57.6% to BRL2.76bn. Net earnings rose to BRL1.4bn from BRL69.9m.

Commenting on the result, CEO Wesley Batista said JBS benefited from its efforts "over the past years" to "create a global production platform". He said: "Today we operate a diversified portfolio, with value-added products and strong brands worldwide. This strategy allows us to generate more solid and consistent results ongoing."

The company added that it remains focused on "operational excellence" and "quality products".

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

Sign up